Co-Diagnostics Inc (CODX): Co-Diagnostics: Additional Factors For C...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	52
Posts	4107
Boards Moderated	0
Alias Born	07/03/2005

Opti Mist

Re: None

Tuesday, 01/12/2021 12:39:58 PM

Tuesday, January 12, 2021 12:39:58 PM

Co-Diagnostics: Additional Factors For Consideration In The Investment Debate
Jan. 12, 2021 11:41 AM ETCo-Diagnostics, Inc. (CODX)3 Likes
Summary
Co-Diagnostics is well positioned to benefit from incremental fundamental momentum seen at the back end of 2020.
The company's Covid-19 tests are differentiated by distinguishing between common cold and SARS-CoV-2 with an easy to use platform.
Given the epidemiology of the common cold and influenza A+B, testing volumes will likely remain high as an exclusion barrier to Covid-19 spread.
We feel the market is unfairly discounting shares and believe shares are worth ~13-$20 in the base and upside case.
Here, we provide investors with additional factors for consideration in the investment debate.
https://seekingalpha.com/article/4398521-co-diagnostics-additional-factors-for-consideration-in-investment-debate?mail_subject=codx-co-diagnostics-additional-factors-for-consideration-in-the-investment-debate&utm_campaign=rta-stock-article&utm_content=link-2&utm_medium=email&utm_source=seeking_alpha

Opti

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.